Open Access

Long‑term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer

  • Authors:
    • Takahiro Einama
    • Hironori Abe
    • Shunsuke Shichi
    • Hiroki Matsui
    • Ryo Kanazawa
    • Kazuaki Shibuya
    • Takashi Suzuki
    • Fumihiko Matsuzawa
    • Taku Hashimoto
    • Nakachi Kohei
    • Shigenori Homma
    • Hideki Kawamura
    • Akinobu Taketomi
  • View Affiliations

  • Published online on: Tuesday, January 10, 2017
  • Pages:163-166 DOI: 10.3892/mco.2017.1128
  • Copyright: © Einama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

0

Abstract

In gastric cancer, primary systemic chemotherapy is the standard approach for the management of patients with initially unresectable metastasis, and it occasionally leads to a reduction in the size of the lesion, which facilitates surgical resection. The aim of this study was to examine the prognosis of patients who were able to undergo complete resection following chemotherapy. A total of 10 patients who underwent radical surgery for stage IV primary gastric cancer after chemotherapy between 2009 and 2015 at the Department of Surgery of Hokkaido Social Work Association Obihiro Hospital (Obihiro, Japan) were retrospectively investigated. Three regimens were used (S‑1, n=1; S‑1 + cisplatin, n=8; and S‑1 + docetaxel, n=1). The mean time from chemotherapy to surgery was 210 days. One total gastrectomy + splenectomy + colectomy, one total gastrectomy + splenectomy, four total gastrectomies and three distal gastrectomies were performed. There were two cases of pancreatic fistula formation postoperatively. All the patients survived for >1 year. Of the 10 patients, 5 survived without recurrence. The median survival time was 871.1 days after diagnosis. Therefore, curative resection after chemotherapy is associated with a better prognosis in stage IV gastric cancer patients.

Related Articles

Journal Cover

February 2017
Volume 6 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Einama, T., Abe, H., Shichi, S., Matsui, H., Kanazawa, R., Shibuya, K. ... Taketomi, A. (2017). Long‑term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer. Molecular and Clinical Oncology, 6, 163-166. http://dx.doi.org/10.3892/mco.2017.1128
MLA
Einama, T., Abe, H., Shichi, S., Matsui, H., Kanazawa, R., Shibuya, K., Suzuki, T., Matsuzawa, F., Hashimoto, T., Kohei, N., Homma, S., Kawamura, H., Taketomi, A."Long‑term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer". Molecular and Clinical Oncology 6.2 (2017): 163-166.
Chicago
Einama, T., Abe, H., Shichi, S., Matsui, H., Kanazawa, R., Shibuya, K., Suzuki, T., Matsuzawa, F., Hashimoto, T., Kohei, N., Homma, S., Kawamura, H., Taketomi, A."Long‑term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer". Molecular and Clinical Oncology 6, no. 2 (2017): 163-166. http://dx.doi.org/10.3892/mco.2017.1128